Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03239418 · ClinicalTrials.gov registry record · NA
NMES to Improve Eyelid Functions in Cranial Nerve (CN) III and VII Palsy
A NA study, sponsored by Brooks Rehabilitation.
- Terminated
- Registry status
- NA
- Development phase
- 26
- Enrollment target
NCT03239418 is a NA study that was terminated before completion, run by Brooks Rehabilitation. The registered enrollment target is 26 participants.
The verdict
NCT03239418, a NA study, was terminated before completion, sponsored by Brooks Rehabilitation.
- TERMINATED
- Registry status
- NA
- Development phase
- 26 participants
- Enrollment target
Study Summary
Traumatic brain injury, stroke and other neurological conditions may result in weakness of the muscles that either open or close the eye. This is generally a result of impaired functioning of the oculomotor or facial cranial nerves. Current treatments to improve eye opening or closing are either invasive or largely ineffective. This study tests a noninvasive means of improving eyelid opening and closing by applying a previously demonstrated safe and effective neuromuscular electrical stimulation (NMES) intervention to the muscles controlling eyelid movement. Participants in this study will either receive the investigational NMES protocol 30 min per day for five days or a sham NMES for the same period. The primary outcome for this study is the participants' ability to open or close their affected eye. Secondary outcomes include additional measures of eye and corneal health.
Interventions
- DEVICE Neuromuscular electrical stimulation
- DEVICE Sham neuromuscular electrical stimulation
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 26 participants |
| Start Date | 2017-01-06 |
| Est. Completion | 2019-10-16 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03239418
The ClinicalTrials.gov registry entry for NCT03239418 describes a study currently listed as terminated, categorized as NA. The registered enrollment target is 26 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Brooks Rehabilitation, which has 5 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Neuromuscular electrical stimulation is the first listed.
NCT03239418 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT03239418 about?
NCT03239418 is a clinical study titled "NMES to Improve Eyelid Functions in Cranial Nerve (CN) III and VII Palsy". Traumatic brain injury, stroke and other neurological conditions may result in weakness of the muscles that either open or close the eye. This is generally a result of impaired functioning of the oculomotor or facial cranial nerves. Current treatments to improve eye opening or closing are either inv...
What is the current status of trial NCT03239418?
This trial is currently terminated. It is a NA study. The enrollment target is 26 participants. The study started on 2017-01-06. Estimated completion is 2019-10-16.
What interventions are being tested in trial NCT03239418?
The interventions under investigation include: Neuromuscular electrical stimulation (DEVICE), Sham neuromuscular electrical stimulation (DEVICE).
Who is sponsoring clinical trial NCT03239418?
This trial is sponsored by Brooks Rehabilitation, which has 5 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.